Literature Review
-
Literature Review
Race, ethnicity may influence outcomes after supratentorial intracerebral hemorrhage
In a cohort of young adults, the percentage of patients with a poor functional outcome after 3 months was 52% among white patients, 35% among...
-
Literature Review
Celecoxib oral solution treats migraine effectively in randomized trial
Migraineurs treated an attack with a single‐dose bottle of DFN‐15 or matching placebo containing 4.8 mL of liquid.
-
Literature Review
Zilucoplan improved efficacy outcomes in myasthenia gravis
The complement C5 inhibitor had a similar magnitude of clinical effect as that seen in eculizumab studies.
-
Literature Review
As costs for neurologic drugs rise, adherence to therapy drops
In patients with Parkinson’s disease, dementia, and neuropathy, higher out-of-pocket drug prices were associated with lower adherence for common...
-
Literature Review
USPSTF again deems evidence insufficient to recommend cognitive impairment screening in older adults
The USPSTF reaffirmed its 2014 statement by concluding that current evidence is insufficient to make a recommendation about screening for...
-
Literature Review
Stress-related disorders linked to later neurodegenerative diseases
Individuals with PTSD, acute stress reaction, adjustment disorder, or other stress reactions had an 80% increased risk of vascular...
-
Literature Review
American Headache Society updates guideline on neuroimaging for migraine
In routine cases with no atypical features, neuroimaging for migraine is unnecessary.
-
Literature Review
Vision symptoms are common and often life-altering for patients with Parkinson’s disease
Two-thirds of patients reported ophthalmologic problems that were severe enough to interfere with activities such as walking, reading, working on...
Conference Coverage
-
Conference Coverage
Shingles vaccine linked to lower stroke risk
Data from a large Medicare database showed a 20% decrease in stroke risk among adults who received the shingles vaccine.
-
Conference Coverage
Higher endovascular thrombectomy volumes yield better stroke outcomes
LOS ANGELES – Thrombectomy for acute ischemic stroke works like other endovascular interventions: The more cases a center does, the better the...
-
Conference Coverage
First clinical evidence of neuroprotection in acute stroke?
LOS ANGELES – A potential neuroprotectant was beneficial for patients with ischemic stroke undergoing thrombectomy in the ESCAPE-NA1 trial.
-
Conference Coverage
More evidence backs LDL below 70 to reduce recurrent stroke
LOS ANGELES – Targeting LDL below 70 mg/dL for more than 5 years avoided more than one in four subsequent major cardiovascular events among adults...
-
Conference Coverage
Pregnancy linked to slowed MS progression
WEST PALM BEACH, FLA. – The study shows women with no full-term pregnancies have earlier onset of progressive MS; the effect appears greater with...
-
Conference Coverage
Cancer increase observed in modern era of MS drugs
WEST PALM BEACH, FLA. – The increased incidence is observed post 1996; the risk is nevertheless called small.
-
Conference Coverage
Phase 2 remyelination trial yields ‘intriguing’ interim results
WEST PALM BEACH, FLA. – VISIONARY-MS has enrolled patients at centers in Australia and recently expanded the trial sites in North America.
-
Conference Coverage
Shared medical appointments educate and encourage MS patients
WEST PALM BEACH, FLA. – The group dynamic tackles social isolation and reduces ER utilization.
-
Conference Coverage
DAPT may benefit symptomatic carotid endarterectomy patients
LOS ANGELES – Observational data suggest dual antiplatelet therapy improves symptomatic-patient outcomes after carotid endarterectomy.
-
Conference Coverage
AUGUSTUS: Apixaban surpassed warfarin despite prior stroke or thromboembolism
LOS ANGELES – Secondary AUGUSTUS analysis showed ACS/PCI patients with AFib plus prior stroke, TIA, or thromboembolism did better on apixaban.
-
Conference Coverage
Hyperlipidemia occurs earlier in patients with MS
WEST PALM BEACH, FLA. – Compared with matched controls, patients with multiple sclerosis have a younger age of hyperlipidemia onset; this effect...
-
Conference Coverage
Age does not appear to affect efficacy of siponimod in secondary progressive MS
WEST PALM BEACH, FLA. – Although siponimod is well tolerated overall, adverse events may lead to discontinuation...
-
Conference Coverage
Manual dexterity may decline more rapidly in pediatric-onset MS
WEST PALM BEACH, FLA. – Age, sex, Patient-Determined Disease Steps, and multiple sclerosis type significantly affect...
-
Conference Coverage
American Academy of Neurology cancels annual meeting amid COVID-19 pandemic
The AAN's annual meeting, scheduled for April 25-May 1, 2020, in Toronto has become the latest medical conference casualty of the COVID-19...
FDA/CDC
-
FDA/CDC
FDA approves first IV migraine prevention drug
“The PROMISE-2 data showed that many patients can achieve reduction in migraine days of at least 75% and experience a sustained migraine...
-
FDA/CDC
FDA OKs first orally disintegrating agent for rapid migraine relief
This is the first CGRP receptor antagonist available in a fast-acting orally disintegrating tablet for the acute treatment of migraine in adults...
Latest News
-
Latest News
Neurologists report low job satisfaction
Isolation from others was their top coping strategy, followed by talking with friends and family and exercise.
-
Latest News
How often do neurologists escalate MS therapy after detecting MRI activity?
-
Latest News
Incomplete MS relapse recovery predicted greater long-term disability
WEST PALM BEACH, Fla. – The findings suggest the need for a stronger focus on the role of relapse recovery.
-
News from the FDA/CDC
TBI deaths from falls on the rise
Death rates from such traumatic brain injuries were up significantly in 29 states from 2008 to 2017, but no state had a significant decrease.